Kenneth Coleman
Keine laufenden Positionen mehr
Profil
Kenneth Coleman worked as a Director at AstraZeneca PLC, Chief Scientific Officer at Novexel SA, Head of Antimicrobial Profiling & Assay Development at Smithkline Beecham Pharmaceuticals (India) Ltd., and Principal at Center for Strategic & International Studies, Inc.
Ehemalige bekannte Positionen von Kenneth Coleman
| Unternehmen | Position | Ende |
|---|---|---|
Center for Strategic & International Studies, Inc.
 Center for Strategic & International Studies, Inc. Miscellaneous Commercial ServicesCommercial Services Center for Strategic & International Studies, Inc. provides strategic insights & policy solutions to decision makers in government, international institutions, the private sector, and civil society. Its projects focus on areas such as AIDS, arms control, conflict resolution, NATO, the environment, immigration, intelligence, trade, health care, OPEC, space policy, and terrorism. The company was founded in 1962 by David M. Abshire and Admiral Arleigh Burke and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Direktor/Vorstandsmitglied | - |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - |
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
Center for Strategic & International Studies, Inc.
Center for Strategic & International Studies, Inc. Miscellaneous Commercial ServicesCommercial Services Center for Strategic & International Studies, Inc. provides strategic insights & policy solutions to decision makers in government, international institutions, the private sector, and civil society. Its projects focus on areas such as AIDS, arms control, conflict resolution, NATO, the environment, immigration, intelligence, trade, health care, OPEC, space policy, and terrorism. The company was founded in 1962 by David M. Abshire and Admiral Arleigh Burke and is headquartered in Washington, DC. | Commercial Services |
